Posted On: 08/07/2013 11:48:40 PM
Post# of 5066
Food For thought: When all is said and done, BMSN will either have a major break through therapy OR end up no the trash bin of biotech blunders.
But keep in mind that there is a reason why this stock is well under a penny. If there was ANY real interest in the technology, BMSN would not be partnerless at this point. Sure, there MIGHT be some interest from Big Pharma (rumors from certain sites are just that, rumors with no concrete evidence what so ever) but it's typical for any ground breaking medical technology to have some form of partnership. What BMSN is attempting to do has not yet captured the interest of any particular company of interest. Let's see what happens if and when the FDA grants IND and orphan status to Hemaxellerate. Until then, all the hyperbole about this company is just that. Again, it's a SUB 1 CENT stock that is down 79% from it's 52 week high.
But keep in mind that there is a reason why this stock is well under a penny. If there was ANY real interest in the technology, BMSN would not be partnerless at this point. Sure, there MIGHT be some interest from Big Pharma (rumors from certain sites are just that, rumors with no concrete evidence what so ever) but it's typical for any ground breaking medical technology to have some form of partnership. What BMSN is attempting to do has not yet captured the interest of any particular company of interest. Let's see what happens if and when the FDA grants IND and orphan status to Hemaxellerate. Until then, all the hyperbole about this company is just that. Again, it's a SUB 1 CENT stock that is down 79% from it's 52 week high.
(0)
(0)
